Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke

Archives of Neurology

Volumn 55, Issue 4, 1998, Pages 466-469

  Grond, Martin ^a   Rudolf, Jobst ^a   Schmülling, Susanne ^a   Stenzel, Christoph ^a   Neveling, Michael ^a   Heiss, Wolf Dieter ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN STEM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RESTENOSIS; TREATMENT PLANNING;

ACUTE DISEASE; ADULT; AGED; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VERTEBROBASILAR INSUFFICIENCY;

EID: 0031945452     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.4.466     Document Type: Article

References (17)

1. Turney TM, Garraway WM, Whisnant JP. The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke. 1984;15:790-794.
2. Hornig CR, Büttner T, Hoffmann O, Dorndorf W. Short-term prognosis of vertebrobasilar ischemic stroke. Cerebrovasc Dis. 1992;2:273-281.
3. Labauge R, Pages M, Marty-Double C, Blard JM, Boukobza M, Salvaing P. Occlusion du tronc basilaire. Rev Neurol. 1981;10:545-571.
4. Becker KJ, Purcell LL, Hacke W, Hanley DF. Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics. Crit Care Med. 1996;24:1729-1742.
5. The National Institute of Neurological Disorders and Stroke r-tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
6. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25:2220-2226.
7. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19:604-607.
8. Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Stroke. 1996;27:875-881.
9. Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216-1222.
10. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology. 1993;35:159-162.
11. Brandt T, Pessin MS, Kwan ES, Caplan LR. Survival with basilar artery occlusion. Cerebrovasc Dis. 1995;5:182-187.
12. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol. 1983;14:294-301.
13. von Kummer R, Forsting M, Sartor K, Hacke W. Intravenous recombinant tissue plasminogen activator in acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer Publishing Co Inc; 1991:161-167.
14. Huemer M, Niederwieser V, Ladurner G. Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry. 1995;58:227-228.
15. Herderscheé D, Limburg M, Hijdra A, Koster PA. Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J Neurol Neurosurg Psychiatry. 1991;54:71-73.
16. Kamps I, Weiss J, Ringelstein EB. Repetitive Behandlung einer subtotalen vertebrobasilären Stenose mit "tissue plasminogen activator" (IPA). Nervenarzt. 1992; 63:755-760.
17. Becker KJ, Monsein LH, Ulatowski J, Mirski M, Williams M, Hanley DF. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol. 1996; 17:255-262.